Financhill
Back

Clinuvel Pharmaceuticals Ltd. Vs. MiNK Therapeutics, Inc. Industry Stock Comparison

Sell
35

CLVLY
Clinuvel Pharmaceuticals Ltd.

Last Price:
$8.38
Seasonality Move:
1.87%
Sell
32

INKT
MiNK Therapeutics, Inc.

Last Price:
$11.68
Seasonality Move:
-18.07%
Sell
35
Clinuvel Pharmaceuticals Ltd. (CLVLY) is a Sell

Is Clinuvel Pharmaceuticals Ltd. a Buy, Sell or Hold?

  • The current Clinuvel Pharmaceuticals Ltd. [CLVLY] share price is $8.38. The Score for CLVLY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • CLVLY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
MiNK Therapeutics, Inc. (INKT) is a Sell

Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?

  • The current MiNK Therapeutics, Inc. [INKT] share price is $11.59. The Score for INKT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CLVLY Stock Price Chart

What is Clinuvel Pharmaceuticals Ltd.'s stock price today?

  • The Clinuvel Pharmaceuticals Ltd. share price today is $8.38
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLVLY is experiencing buying pressure, which is a positive indicator for future bullish movement.

INKT Stock Price Chart

What is MiNK Therapeutics, Inc.'s stock price today?

  • The MiNK Therapeutics, Inc. share price today is $11.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing slight buying pressure.

CLVLY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.24 Buy
Relative Strength Index (14 RSI): 66.05 Buy
Chaikin Money Flow: 2661 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.2 - 8.26) Buy
Bollinger Bands (100): (7.25 - 8.15) Buy

INKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 44.79 Sell
Chaikin Money Flow: 9780 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.89 - 12.35) Sell
Bollinger Bands (100): (12.23 - 15.15) Sell

CLVLY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.24 Buy
20-day SMA: 7.88 Buy
50-day SMA: 7.62 Buy
200-day SMA: 7.4 Buy
8-day EMA: 8.21 Buy
20-day EMA: 7.97 Buy
50-day EMA: 7.74 Buy
200-day EMA: 7.69 Buy

INKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.09 Sell
20-day SMA: 11.62 Sell
50-day SMA: 12.8 Sell
200-day SMA: 11.89 Sell
8-day EMA: 11.86 Sell
20-day EMA: 11.96 Sell
50-day EMA: 12.6 Sell
200-day EMA: 12.22 Sell

Clinuvel Pharmaceuticals Ltd. Earnings Growth & CLVLY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.

Clinuvel Pharmaceuticals Ltd. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

MiNK Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):